169 related articles for article (PubMed ID: 3104814)
21. Role of central dopaminergic and 5-hydroxytryptaminergic projections in the behavioral responses elicited by thyrotropin-releasing hormone in rats.
Funk D; Post RM; Pert A
Psychopharmacology (Berl); 1997 Oct; 133(4):356-62. PubMed ID: 9372535
[TBL] [Abstract][Full Text] [Related]
22. Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens.
McCullough LD; Salamone JD
Brain Res; 1992 Apr; 577(1):1-9. PubMed ID: 1521135
[TBL] [Abstract][Full Text] [Related]
23. The TRH analogue CG3509 increases in vivo catechol/ascorbate oxidation in the N. accumbens but not in the striatum of the rat.
Sharp T; Brazell MP; Bennett GW; Marsden CA
Neuropharmacology; 1984 Jun; 23(6):617-23. PubMed ID: 6431310
[TBL] [Abstract][Full Text] [Related]
24. Actions of substance P, MIF, TRH and related peptides in the substantia nigra, caudate nucleus and nucleus accumbens.
Pinnock RD; Woodruff GN; Turnbull MJ
Neuropharmacology; 1983 Jun; 22(6):687-96. PubMed ID: 6193454
[TBL] [Abstract][Full Text] [Related]
25. A TRH analog (DN-1417): motor stimulation with rearing related to catecholaminergic mechanisms in rats.
Miyamoto M; Narumi S; Nagai Y; Saji Y; Nagawa Y
Neuropharmacology; 1984 Jan; 23(1):61-72. PubMed ID: 6425711
[TBL] [Abstract][Full Text] [Related]
26. Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
Rakovska A; Baranyi M; Windisch K; Petkova-Kirova P; Gagov H; Kalfin R
Brain Res Bull; 2017 Sep; 134():246-252. PubMed ID: 28802898
[TBL] [Abstract][Full Text] [Related]
27. Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats.
Melis MR; Melis T; Cocco C; Succu S; Sanna F; Pillolla G; Boi A; Ferri GL; Argiolas A
Eur J Neurosci; 2007 Aug; 26(4):1026-35. PubMed ID: 17672853
[TBL] [Abstract][Full Text] [Related]
28. Effect of DN-1417, a thyrotropin releasing hormone analog, on dopaminergic neurons in rat brain.
Nakahara T; Matsumoto T; Hirano M; Uchimura H; Yokoo H; Nakamura K; Ishibashi K; Hirano H
Peptides; 1985; 6(6):1093-9. PubMed ID: 3938840
[TBL] [Abstract][Full Text] [Related]
29. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol.
Imperato A; Di Chiara G
J Pharmacol Exp Ther; 1986 Oct; 239(1):219-28. PubMed ID: 3761194
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (II): Involvement of the DA system in the locomotor stimulating action of TA-0910.
Yamamura M; Kinoshita K; Nakagawa H; Ishida R
Jpn J Pharmacol; 1991 Jan; 55(1):57-68. PubMed ID: 1904114
[TBL] [Abstract][Full Text] [Related]
31. Involvement of nucleus accumbens dopamine in the motor activity induced by periodic food presentation: a microdialysis and behavioral study.
McCullough LD; Salamone JD
Brain Res; 1992 Oct; 592(1-2):29-36. PubMed ID: 1450917
[TBL] [Abstract][Full Text] [Related]
32. Dopamine in the basal ganglia and benzodiazepine-induced sedation.
Brose N; O'Neill RD; Boutelle MG; Fillenz M
Neuropharmacology; 1988 Jun; 27(6):589-95. PubMed ID: 3419542
[TBL] [Abstract][Full Text] [Related]
33. [A TRH analog (DN-1417). Effects on the levels of monoamines and the metabolites in the various brain regions in rats].
Nagai Y; Narumi S; Miyamoto M; Shima T; Saji Y; Nagawa Y
Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):209-20. PubMed ID: 3924795
[TBL] [Abstract][Full Text] [Related]
34. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons.
Kalivas PW; Duffy P
J Pharmacol Exp Ther; 1987 Apr; 241(1):204-12. PubMed ID: 3572784
[TBL] [Abstract][Full Text] [Related]
35. Administration of thyrotropin releasing hormone (TRH) to rats releases dopamine in n. accumbens but not n. caudatus.
Heal DJ; Green AR
Neuropharmacology; 1979 Jan; 18(1):23-31. PubMed ID: 105304
[No Abstract] [Full Text] [Related]
36. Effect of injection of thyrotropin-releasing hormone into nucleus accumbens on pain discharges in nucleus parafascicularis of the thalamus in rats.
Nie ZG; Liu ZY
J Tongji Med Univ; 1991; 11(4):198-203. PubMed ID: 1819028
[TBL] [Abstract][Full Text] [Related]
37. Effects of 5-HT3 receptor-selective agents on locomotor activity in rats following injection into the nucleus accumbens and the ventral tegmental area.
Gillies DM; Mylecharane EJ; Jackson DM
Eur J Pharmacol; 1996 May; 303(1-2):1-12. PubMed ID: 8804905
[TBL] [Abstract][Full Text] [Related]
38. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats.
Robinson TE; Jurson PA; Bennett JA; Bentgen KM
Brain Res; 1988 Oct; 462(2):211-22. PubMed ID: 2847849
[TBL] [Abstract][Full Text] [Related]
39. Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow.
Koeltzow TE; Austin JD; Vezina P
Neuropharmacology; 2003 Jan; 44(1):102-10. PubMed ID: 12559127
[TBL] [Abstract][Full Text] [Related]
40. Systemic administration of thyrotropin-releasing hormone enhances striatal dopamine release in vivo.
Kreutz MR; Acworth IN; Lehnert H; Wurtman RJ
Brain Res; 1990 Dec; 536(1-2):347-52. PubMed ID: 1707722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
